Advertisement
Lefkofsky's Tempus raises $70 million

Lefkofsky's Tempus raises $70 million

By John Pletz  |  September 25, 2017

Tempus, Eric Lefkofsky's cancer-data company, is getting a $70 million boost from some familiar partners: New Enterprise Associates and Revolution Growth. The two Washington, D.C.-area venture funds led a new round of financing that brings the total outside investments in Tempus to $130 million.

Singleton to retire as CEO of Inova after 35 years

Singleton to retire as CEO of Inova after 35 years

By Maria Castellucci  |  September 15, 2017

Singleton oversaw the growth of the Falls Church, Va.-based system from $500 million to $3.3 billion in revenue. Recently, he was involved in efforts to bolster Inova's position as a national leader in precision medicine and cancer research.

New cancer center at Henry Ford to break ground

New cancer center at Henry Ford to break ground

By Associated Press  |  June 06, 2017

Plans are moving forward for a new cancer care facility in Detroit. A groundbreaking event takes place Tuesday for the Brigitte Harris Cancer Pavilion, which will be part of the Henry Ford Cancer Institute.

Soon-Shiong unfazed by critics as he touts new cancer therapy

Soon-Shiong unfazed by critics as he touts new cancer therapy

By Maria Castellucci  |  June 06, 2017

In an interview with Modern Healthcare this week, Soon-Shiong said his company's new cancer therapy gets to the root causes of the disease. He also said that recent reports questioning the success of his company's therapies are based on "ignorance," which he "ignores."

Few doctors discuss cancer costs with patients, study finds

By Associated Press  |  May 18, 2017

Most doctors did not discuss the cost of cancer treatment with patients, spent less than two minutes on it when they did, and usually did so only after patients brought it up, a study that taped hundreds of visits at several large hospitals finds.

Trendy charred food: Is it worth the risk?

Trendy charred food: Is it worth the risk?

By Modern Healthcare  |  February 04, 2017

Charred food may be one of the latest fads at fashionable restaurants—at least according to the New York Times food section—but there seems to be a dark side to this trend.

Data Points: Cancer's toll by race and geography

Data Points: Cancer's toll by race and geography

By Modern Healthcare  |  January 28, 2017

The U.S. cancer mortality rate, in steady decline for over three decades, still takes a higher toll on African Americans. Regional disparities persist, too, with some areas of the country seeing worsening cancer mortality rates.

Where you live could be a matter of life or death if you get cancer

By Steven Ross Johnson  |  January 24, 2017

Cancer deaths have declined in the U.S. over the past three decades, but mortality rates can vary greatly depending on the county where you live. Researchers say that information could better inform treatment and prevention efforts in certain communities.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print